GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    The Endocrine Society ; 2005
    In:  The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 10 ( 2005-10-01), p. 5825-5833
    In: The Journal of Clinical Endocrinology & Metabolism, The Endocrine Society, Vol. 90, No. 10 ( 2005-10-01), p. 5825-5833
    Abstract: Context: Normal glucose homeostasis is maintained despite reductions in insulin sensitivity by increasing insulin secretion. This ability to compensate for reduced insulin sensitivity is highly heritable, but the mechanisms for this compensation or its failure in type 2 diabetes (T2DM) are unknown. Objective: The objective of this study was to test whether individuals with a family history of T2DM have a fixed decrease in β-cell mass or function that would be revealed as an impaired insulin secretory response to short-term insulin resistance. Design: Glucose tolerance, insulin sensitivity (SI), and insulin response to iv glucose (AIRG) were compared in nondiabetic individuals with and without a family history of diabetes before and after nicotinic acid (NA) treatment. Setting: This study was performed at the Ambulatory General Clinical Research Center. Subjects: Healthy, nonobese, nondiabetic individuals with or without a family history of T2DM were studied. Interventions: Oral NA was given, with a final dose of 2 g/d, for at least 7 d. Main Outcome Measure: The main outcome measure was the disposition index (insulin sensitivity × insulin response) in response to NA. Results: Postchallenge plasma glucose levels rose during NA therapy regardless of family history. Neither group adequately increased their AIRG to maintain the disposition index. Family members did not differ from controls at baseline or after NA treatment for any outcome measure, but only 28 of 52 subjects experienced a 25% or greater fall in SI with NA treatment. Conclusions: Short-term β-cell compensation to NA-induced insulin resistance was incomplete and did not differ by genetic predisposition. A genetic defect controlling β-cell growth in response to chronic insulin resistance better explains differences in the ability to compensate for insulin resistance than an inherited, fixed defect in β-cell mass.
    Type of Medium: Online Resource
    ISSN: 0021-972X , 1945-7197
    RVK:
    Language: English
    Publisher: The Endocrine Society
    Publication Date: 2005
    detail.hit.zdb_id: 2026217-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...